immuntherapie-krebs.net | Immuntherapie Krebs | dendritische Zelltherapie | dendritic cell

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
google-site-verification=8RDk9ZgltArL5Q0VrikINUqa_IOKs0vMW8uQnKIT3LM

Meta Tags

Title	Immuntherapie Krebs \| dendritische Zelltherapie \| dendritic cell \| Krebstherapie \|
Description	IMMUMEDIC Immuntherapie bei Krebsdiagnose kann Menschen helfen den Tumor optimal und nachhaltig zu bekämpfen, die Nebenwirkungen sind gering und damit bleibt die Lebensqualität erhalten. Die antigenpräsentierenen dendritischen Zellen gewonnen aus dem Blut der
Keywords	N/A

Server Information

WebSite	immuntherapie-krebs.net
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

immuntherapie-krebs.net Valuation

US$830

Last updated: 2023-05-17 21:31:40

immuntherapie-krebs.net has Semrush global rank of 0. immuntherapie-krebs.net has an estimated worth of US$ 830, based on its estimated Ads revenue. immuntherapie-krebs.net receives approximately 95 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, immuntherapie-krebs.net is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$830
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$23
Yearly Ads Revenue	US$276
Daily Unique Visitors	6
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
immuntherapie-krebs.net. 3600	A	immuntherapie-krebs.net. 3600	IP: 185.230.63.186
immuntherapie-krebs.net. 3600	A	immuntherapie-krebs.net. 3600	IP: 185.230.63.107
immuntherapie-krebs.net. 3600	A	immuntherapie-krebs.net. 3600	IP: 185.230.63.171
immuntherapie-krebs.net. 86400	NS	immuntherapie-krebs.net. 86400	NS Record: ns2.wixdns.net.
immuntherapie-krebs.net. 86400	NS	immuntherapie-krebs.net. 86400	NS Record: ns3.wixdns.net.
immuntherapie-krebs.net. 3600	MX	immuntherapie-krebs.net. 3600	MX Record: 20 alt1.aspmx.l.google.com.
immuntherapie-krebs.net. 3600	MX	immuntherapie-krebs.net. 3600	MX Record: 30 alt2.aspmx.l.google.com.
immuntherapie-krebs.net. 3600	MX	immuntherapie-krebs.net. 3600	MX Record: 40 alt3.aspmx.l.google.com.
immuntherapie-krebs.net. 3600	MX	immuntherapie-krebs.net. 3600	MX Record: 10 aspmx.l.google.com.
immuntherapie-krebs.net. 3600	MX	immuntherapie-krebs.net. 3600	MX Record: 50 alt4.aspmx.l.google.com.
immuntherapie-krebs.net. 3600	TXT	immuntherapie-krebs.net. 3600	TXT Record: google-site-verification=-qJ6xrSE7vq92TN8ra0Q8Ib0fC2OHyaNhIXJKeQg7p8

HtmlToTextCheckTime:2023-05-17 21:31:40

top of page Newsletter 0 New News im Blog Eilmeldung - Multiorganversagen - Krebs Log In immunotherapy cancer treatments treatments Hyperthermie dendritische Zelltherapie immune boost stem cells treatments Cancer Counselor Cancer Counselor Services Services Press Press Services Press Press studies Blog imprint privacy Terms of Service Contact Contact stem cells stem cells Suchergebnisse Shop IMMUMEDIC International The Cell Factory Immunotherapy in cancer diagnosis IMMUMEDIC Limited is an international medical services provider based in Ireland. We work nationally and internationally with a wide variety of physicians/doctors/scientists/laboratories. In the interests of our customers, we deliver the right autologous cells for a wide variety of therapy options reliably, punctually and precisely. The GMP partner laboratories produce autologous dendritic cells obtained from the blood of the affected patients. Stem cell databases supply stem cells from umbilical cord blood Stem cells from

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 21 Apr 2022 09:41:26 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.immuntherapie-krebs.net/en
strict-transport-security: max-age=3600
cache-control: no-cache
x-wix-request-id: 1650534086.48929690453014923
Age: 0
X-Seen-By: gv/XVF9HsGpk8A2KWukUzCWfEJXUOf1J0Ah0dFlolkk=,m0j2EEknGIVUW/liY8BLLjmaS7Ki5l/bn9NiiirFyVEm++C2XkuTvnlRFg2XiSDL,2d58ifebGbosy5xc+FRalqGieThnSL7rg+ZXOh5b1Y85zwRU1kKFheIPUuYPNavuK2BwoEMURkUNuU9c1ZTgiQ==,2UNV7KOq4oGjA5+PKsX47PGnwEa4ahDGUcZoML+4h9BjPZTuGyYqVhtmEIgJUb4w,R8nVwPJv9QJL1m78OROO+HD7+0T3c7jJ3ZWP/tnLfG4=,g1tEHL6KXqacD6ojcO5kMoMLbgUEjKFzX8t3/d0cnQ5YgeUJqUXtid+86vZww+nL,kO0u+7q+TL0DeeE//9W7MCfeX5JiguB9U+FBaMV6TsQSO5XmrrCSQNDehIjmfew3/+DhqSdNthzOPcQYgL4h2A==
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 21 Apr 2022 09:41:27 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1650534086.689749676847918870
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMdks7Ya+yJLQ6m1r9zCim+t,qquldgcFrj2n046g4RNSVOEcKTWnPkUHK4qOWpouMik=,2d58ifebGbosy5xc+FRalra9rOMkqmfxeiLTZHdzn3xIQFzALmMabMFNnSgobs3F3QpI/ucnHvfrUjeESIoVeqwH2KF8b/lNAvPEiuuB7xM=,2UNV7KOq4oGjA5+PKsX47Dup3Er3OeJdBpGMGRuuaaaa46R9xNIlpQ4eUPYpBuqs,4EmzKGKKpFffqfFwZRPY8X2MhkJ0kaCnvSOi5QCbvkY+9eoOWhRJq1bRSLfhrrYEmjnKFPl/pvYHR9Cuf1OO5Q==,xTu8fpDe3EKPsMR1jrheEBPTVUXKdl1Fxe9Us5e4cT8=,7npGRUZHWOtWoP0Si3wDp6IpRD2VaYYxcFPdlOF8k1A=,xTu8fpDe3EKPsMR1jrheEIXGF0PZkMk9u+Hyw5PT05s=,LoUK8/saGAmOxZWtpubo2nxCJA0fbhwSxwGigZZi9g28Tt4X9bKNJSPXY50afb2SMH0SrTKB57MAm3qa+jvtqg==,xTu8fpDe3EKPsMR1jrheEIXGF0PZkMk9u+Hyw5PT05s=,7npGRUZHWOtWoP0Si3wDpxqCMNSYGgv2WmRMx5BcsBQ=,xTu8fpDe3EKPsMR1jrheEE1kLzpBfVyO0/stW1UdhkM=,/a5ccLSK1HEmwPNg/x6OuovF2iG/dpQ+I4g3h1UfstlcaQoaMfqVMaltgb95fDG4G+N1NOK+0YwQynt66p4sdQ==
cache-control: no-cache
vary: Accept-Encoding,Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Thu, 21 Apr 2022 09:41:47 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

immuntherapie-krebs.net Whois Information

Domain Name: IMMUNTHERAPIE-KREBS.NET
Registry Domain ID: 2674199789_DOMAIN_NET-VRSN
Registrar WHOIS Server: whois.wix.com
Registrar URL: http://www.wix.com
Updated Date: 2022-02-10T15:41:26Z
Creation Date: 2022-02-10T15:41:26Z
Registry Expiry Date: 2024-02-10T15:41:26Z
Registrar: Wix.com Ltd.
Registrar IANA ID: 3817
Registrar Abuse Contact Email: domain-abuse@wix.com
Registrar Abuse Contact Phone: +14154291173
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-21T10:32:52Z <<<

immuntherapie-krebs.net valuation and analysis